Sir, Aggressive behavior is usually an unwanted serious behavior and there are many reports in psychological medicine on the underlying genetic factors. Of several genetic polymorphisms, monoamine oxidase A (MAOA) polymorphism is widely mentioned for the clinical relationship to aggressive behavior. [1] In a recent reported, it was proved that having short polymorphism is related to the increased risk behavior and harmful practice comparing to having long polymorphism. [2] Indeed, based on the basic concern on quantum molecular genetics, the genetic molecular mass change due to different polymorphism can be expected. It is no doubt that the patients with short polymorphism have a less molecular weight of MAOA comparing to those with long polymorphism and this means less catalysis of monoamine can be expected in ones with short polymorphism. Indeed, the high accumulated level of the monoamine is proved to relate to the agitation state in psychiatric patients, [3] and the observation might be well relating to the already mentioned effect of short versus long MAOA polymorphism. The effects of molecular mass change can be well demonstrated for case aggressive behavior and MAOA short and long polymorphism, similar to that seen in other polymorphism related medical disorders. [4, 5] Financial support and sponsorship Nil.
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If Depression may be Associated with Future Care Seeking of Activity-limiting Low Back Pain, We Must Properly Address the Depression as Well
Sir, It has long been known that chronic pain and psychiatric illness are intertwined between one another. The most recent global burden of diseases study indicated low back pain (LBP) and depression comprise the top two leading causes of disability worldwide, where disability is assessed by years lived with disability. [1, 2] Pinheiro et al. in their follow-up study, "Symptoms of Depression and Risk of LBP: A Prospective Co-Twin Study, [3] " attempted to investigate whether symptoms of depression increase the risk of chronic LBP with the use of a prospective study design, but with the important adjustment for important confounders including genetic factors, thus the utilization and inclusion of twins.
Although their results did not suggest a possible causal link between depression and LBP (given that no association was found, when genetic and early environmental factors are controlled for), their study did in fact find a significant association between trait depression and future care seeking and activity-limiting LBP. [3] Now, for providers in training and those already practicing, this is an important point to take notice of.
For those who are in the early stages of training, it is imperative that a provider develops good skills and habits earlier rather than later, which will ultimately provide them with the tools to become a better overall clinician. This study focuses on the important finding that patients with depression are more likely to have activity-limiting LBP, whom will have an increased likelihood of seeking care. There are a few points providers must be acutely aware of to be better prepared to address moving forward with their patients.
First, patients who are depressed are more likely to present for specific treatment of their activity-limiting LBP. [3] As a provider, it is imperative to utilize their time in training to garner the skillset to be able to establish a rapport with my new patient, gather a detailed history, and then perform a thorough physical examination that includes a detailed neurological assessment. From this point, the provider must be able to formulate a patient-specific, tailored care plan that may include radiographic imaging, medication management, and of course, potential interventional diagnostic and therapeutic procedures, with the end goal of reduction or potential elimination of their chronic LBP.
The second thing to be aware of is their concurrent depression. This, in fact, could be the more significant point that chronic pain providers may unfortunately not fully address or allocate their patients' visit time too. Although they may already have been diagnosed with depression, have established care with a psychiatrist or primary care physician who is prescribing them appropriate medications, and concurrently, having frequent therapy appointments with a counselor or therapist, the reality is majority of these patients will not be presenting to you for and implication in patients with renal transplantation. J Nephropharmacol 2016;6:19-20. 5. Joob B, Wiwanitkit V. ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1) polymorphism and clopidogrel concentration in acute coronary syndrome: Molecular change can explain the observed therapeutic concentration. Anatol J Cardiol 2016;16:303-4.
